Kintara Therapeutics, Inc.
KTRA
Revenue
0.00
0.000.00%
3 Months ChangeAssets
6.20M
▼-1.24M▼-16.71%
3 Months ChangeLiabilities
2.45M
▲921.00k▲60.43%
3 Months ChangeFree Cash Flow
-7.23M
▼-7.23M-∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-07-01
Form 8-K
ID: 0000950170-24-079280
2024-06-24
Form 8-K
ID: 0000950170-24-076467
2024-06-13
Form 8-K
ID: 0000950170-24-072991
2024-06-03
Form 8-K
ID: 0000950170-24-067670
2024-05-14
Form 8-K
ID: 0000950170-24-059716
2024-05-14
Form 10-Q
ID: 0000950170-24-059694
2024-05-09
Form 8-K
ID: 0000950170-24-057263
2024-04-25
Form 8-K
ID: 0000950170-24-047950
2024-04-03
Form 8-K
ID: 0000950170-24-040655
2024-02-27
Form 8-K
ID: 0000950170-24-020612